Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of bioactive molecules targeting central nervous system disorders. Its structure supports the construction of complex heterocyclic systems found in experimental therapeutics, including those with potential antipsychotic or antidepressant activity. The tert-butyl carbamate group serves as a protecting group for amines during multi-step syntheses, enabling selective reactions. Additionally, the presence of the trifluoromethyl moiety enhances metabolic stability and lipophilicity, which are desirable traits in drug design. Commonly employed in medicinal chemistry research for scaffold modification and structure-activity relationship studies.